R. Kent Jr McGaughy - Jun 8, 2022 Form 4 Insider Report for REATA PHARMACEUTICALS INC (RETA)

Role: Director, 10%+ Owner
Signature: /s/ R. Kent McGaughy, Jr.
Stock symbol: RETA
Transactions as of: Jun 8, 2022
Transactions value $: $114,984
Form type: 4
Date filed: 6/10/2022, 06:33 PM
Previous filing: May 25, 2022
Next filing: Jun 16, 2022
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RETA	Stock Option (right to buy)	Award	$0	+11.2K		$0.00	11.2K	Jun 8, 2022	Class A common stock	11.2K	$34.76	Direct	F1
transaction	RETA	Stock Option (right to buy)	Award	$115K	+4.79K		$24.02	4.79K	Jun 8, 2022	Class A common stock	4.79K	$34.76	Direct	F1, F2

Showing 1 to 2 of 2 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The options vest in 4 equal installments on September 14, 2022, December 8, 2022, March 1, 2023, and June 7, 2023, subject to continued service through each vesting date.
F2	These options were issued to the reporting person pursuant to the Reata Non-Employee Director Compensation Policy in lieu of future director fees of $115,000.